Check Your Email: Updates From Your ACG Governor
From the ACG Board of Governors Chair Dayna S. Early, MD, FACG and Vice Chair Sita S. Chokhavatia, MD, FACG, MACG
Check your email inboxes for an update for your ACG Govenor, providing the latest news from the College, as well from your local area. We urge you to contact your ACG Governor on important issues impacting our practices and patients.
Can't find the email? Please check your spam/junk folders, then allow access to these updates in the future!
The ACG Board of Governors is one of the most unique aspects of the College’s governance. Governors are elected from the membership of a particular state or region and act as a two-way conduit between the ACG leadership and the membership at-large. This helps meet the evolving needs of our membership. ACG Governors also act as a grassroots advocacy force at both the national and state levels.
Other Notable News in GI
Only one-half of positive stool tests get follow-up colonoscopy: HealthDay News reports on a new study that found of almost 33,000 people at average risk for colon cancer, just 56% who had a positive result from a stool test had followed up with a colonoscopy within a year. Socioeconimc status and the COVID-19 pandemic were associated with lower follow-up rates. The findings were published in JAMA Network and based on screenings between 2017-2020.
FDA grants accelerated approval colorectal cancer treatment: MedPage reports that the U.S. Food and Drug Adminstration (FDA) has granted accelerated approval to tucatinib (Tukysa) in combination with trastuzumab (Herceptin) for adult patients with RAS wild-type, HER2-positive unresectable or metastatic colorectal cancer who have progressed following treatment with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy. It is the first FDA-approved treatment for HER2-positive metastatic colorectal cancer.
Get Inspired to "Go Blue" for CRC Awareness Month
The Colon Cancer Coalition invites ACG members to join a national effort with patient advocates to illuminate landmarks blue and raise awareness of colorectal cancer prevention. Click here for resources, best practices, templates, and inspiration!
